United States: Telehealth In 2017: What Changed And What's Ahead

As the U.S. shifts from a fee-for-service (FFS) system to a value-based system, healthcare IT will become an increasingly important component in fostering patient engagement, coordinating care, increasing access to services, and decreasing overall costs. Telemedicine, in particular, is viewed by many as the solution for achieving access to care and cost-efficiency. Concluding 2017, this article looks back on some of the legal and regulatory changes that occurred with respect to telemedicine as well as areas of interest to watch in 2018.

I. State-Level Changes

On December 15, 2016, the Federation of State Medical Boards (FSMB) released their "2016 State Medical Board Survey" which was completed by 57 of the 70 state medical licensing boards in the U.S. and its territories, identifying their most pressing issues.i The FSMB reported that 75% of boards chose telemedicine as one of the most important regulatory topics of 2017, securing the top spot in the survey. This report rang true this year as many licensing boards reconsidered existing telemedicine rules or created new telemedicine licensing frameworks altogether.

In-Person Examination Requirements (Texasii, Oklahomaiii, Indianaivand Michiganv

Indiana and Michigan each passed laws removing requirements for an in-person examination prior to prescribing via telemedicine. The Michigan law is more expansive and applies to all prescriptions. To prescribe controlled substances via telemedicine in Indiana, however, the patient must have been examined in-person by a licensed Indiana healthcare provider and the prescriber must have reviewed that provider's treatment plan and issued a prescription pursuant to that plan.

Up until recently, Texas remained the last holdout state requiring an in-person visit before delivering healthcare services via telemedicine.vi In May, SB 1107 was signed into law, eliminating the requirement for a "face-to-face" consultation to initiate a physician-patient relationship. In November, the Texas Medical Board issued new regulations implementing the statutory changes.

Originating Sites (Arkansasvii, Hawaiiviii, Texasix, Vermontx)

Several states relaxed restrictions on eligible originating sites for telemedicine, permitting services in locations such as patient homes and schools. Arkansas revised its definition of an "originating site" to "anywhere a patient is located", while Texas removed its requirement that telemedicine services only be provided at "established medical sites." Hawaii and Vermont each added patient homes and other non-medical sites to the definition of "originating sites." Louisiana removed its requirement that physicians practicing telemedicine maintain an office in the state or contract with in-state providersxi.

Adoption of Telemedicine Practice Acts (New Jerseyxii, Illinoisxiii, Wisconsinxiv)

Three states that previously did not formally address the provision of telemedicine services adopted new frameworks. New Jersey enacted SB 291 explicitly authorizing healthcare providers to provide telemedicine services so long as a provider-patient relationship has been established. An initial in-person examination is not required; however, the provider must review the patient's medical history and available medical records prior to the initial telemedicine encounter. Illinois's Public Act 100-0317 created the Telehealth Act which permits the provision of telemedicine by Illinois-licensed health care professionals. Previously silent with regard to telemedicine practice, new Wisconsin Board rules now define telemedicine, explain how a valid physician-patient relationship can be established in a telemedicine setting, and identify technology requirements for physicians who use telemedicine.

Reimbursement Expansion (Arkansas, Hawaii, Indiana, Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Jersey, North Dakota, Ohio, Pennsylvania, South Dakota, Tennessee, Utah, Vermont, West Virginia, and Wyoming)

Many states revised their Medicaid regulations to expand reimbursement for telemedicine services. In addition, several states enacted parity laws with respect to commercial payors or their Medicaid Programs, or both, requiring coverage and/or reimbursement of telemedicine services to the same extent as services delivered in-person.

Despite this expansion trend, both North Carolinaxv and South Carolinaxvi clarified that their Medicaid programs will not reimburse for store-and-forward and placed further limitations based on the location of services. New Hampshire's Medicaid reimbursement for telemedicine also has significant limitations, adopting Medicare's coverage policies with respect to modalities, originating sites, eligible services, and distant sites.xvii

Expansion of Telemental Health

There were many state-level advancements in telemental health relating to the provision of services, reimbursement, and prescribing. In particular, licensing boards across the country have noted a lack of access to mental health services by certain populations and a desire to reach those individuals through the use of technology. For example, in New York, telehealth regulations were relaxed to enable mental health providers to treat some patients online in certain patient care settings. Under the new Texas telemedicine regulations, restrictions on the provision of mental health services via telemedicine were relaxed and the list of eligible service providers was expanded.

Public Safety

Other states made slight changes to their telemedicine requirements to balance public safety concerns: (1) Alaska implemented regulations requiring businesses to register with the Telemedicine Business Registry prior to providing telemedicine services to patients located in the statexviii; (2) Connecticut passed a law prohibiting prescribing of ocular lenses without an in-person eye examinationxix; and (3) Texas regulations include both a requirement to provide a Notice of Privacy Practices as well as a limitation on the issuance of prescriptions via telemedicine for the treatment of chronic painxx.

II. Status of Interstate Medical Licensure Compact (IMCL)

The IMLC is an agreement between participating states and their licensing boards to qualify physicians to practice medicine across state lines, if they meet the agreed upon eligibility requirements. The licensure application process is expedited by leveraging the physicians' existing information submitted in their state of principal license. Once qualified, the physician may select any number of compact states where they desire to practice. Four states passed laws to join the IMLC in 2017 (Washington, Nebraska, Tennesseexxi, and Maine. IMLC's application process officially went live on April 6, 2017, and its first license was issued on April 20, 2017.xxii Compact legislation has also been introduced in Michigan, Rhode Island, Texas, the District of Columbia, and Guam.

III. Status of Parity Lawsxxiii

Additional states enacted parity laws in 2017 (Nebraska, New Jersey, North Dakota, and Vermont) and others amended their parity laws to remove originating site restrictions (e.g., Arkansas and Washington).

Currently, 34 states and D.C. have some form of parity law for telemedicine and another 8 states have proposed parity legislation (Idaho, Kansas, Iowa, Ohio, West Virginia, Pennsylvania, North Carolina, Massachusetts.)

IV. Reimbursement Changes

Medicare

No changes were made to Medicare's statutory coverage of telemedicine or its implementing regulations. However, the annual updates to the Medicare Physician Fee Schedule included the new codes for ESRD services, advanced care planning services, and critical care consultations, that are now eligible for reimbursement if other Medicare coverage criteria are met.

Medicaid

Currently, 48 states and D.C. provide some coverage for telemedicine in their Medicaid FFS.xxiv Despite this seemingly widespread coverage, however, the states widely differ in terms of the telemedicine services covered, the provider types covered, location of the patient, form of telemedicine delivery, and overall geography. New Hampshire, for example, only offers telemedicine services to Medicaid beneficiaries within rural areas as defined by Medicare guidelines.

Nevada and Hawaii joined the ranks of state Medicaid programs that reimburse for store-and-forward services and Kentucky and Hawaii now reimburse for remote patient monitoring. As noted above, Arkansas, Hawaii, Indiana, Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Jersey, North Dakota, Ohio, Pennsylvania, South Dakota, Tennessee, Utah, Vermont, West Virginia, and Wyoming amended their Medicaid reimbursement policies for telemedicine to offer expanded coverage.

Employer-Sponsored Health Plans

Commercial plans have expanded their coverage of telemedicine services under employer-sponsored health plans, particularly with respect to behavioral health services. Healthcare represents an enormous expense to U.S. employers — averaging $12,229 per employee, or 14% of total payroll, according to the 2017 Mercer National Survey of Employer-Sponsored Health Plans.xxv The Mercer survey further noted that 71% of employers with 500 or more employees offered coverage for telemedicine services, up sharply from 59% last year, and this number is expected rise as employers seek to control healthcare costs.

V. Federal Expansion of Telemedicine

Federal Bills

Several telemedicine bills were advanced in Congress this year; however, none have been enacted.xxvi The Senate unanimously passed the Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (S.870) in September and it now sits in the House Subcommittee on Health.xxvii The CHRONIC Care Act includes four important telemedicine provisions: (i) MA plans may include additional telemedicine services in their bids, (ii) certain ACOs have additional flexibility to provide telehealth, (iii) beneficiaries receiving dialysis treatments at home may do their monthly check-in visit via telemedicine; and (iv) removes Medicare's originating site coverage restriction for evaluations of an acute stroke. For its part, the House advanced three separate bills this year with provisions similar to those included in the CHRONIC Care Act: expanding telemedicine services under Medicare Advantage (HR 3727), expanding telemedicine for stroke patients (HR 1148), and expanding the use of telemedicine to facilitate the use of home dialysis (HR 3178). Given the bipartisan support for these bills in each chamber, telemedicine advocates are hopeful for legislation in the near future.

Federal Communications Commission (FCC) – Repeal of Net Neutrality and Increased Funding for Rural Broadband

Net neutrality rules provide that internet service providers cannot speed up, slow down, or block any content, applications, or websites. On December 14, 2017, the FCC voted to repeal the net neutrality rules resulting in considerable uncertainty about how this change will affect the healthcare industry, particularly related to telemedicine. FCC Chairman Ajit Pai has argued that the government's light touch approach to high-speed internet will be a net benefit for telemedicine. Industry experts, however, worry that the FCC's reforms will be problematic for healthcare providers, telemedicine vendors, and patients, all of whom require robust connectivity to meet the demands of video consultations that could come at a higher cost. Continued attention should be paid to this heading into 2018.

The FCC has issued a request for public comment to its proposal to increase the $400 million annual cap on the Rural Health Care Program (RHCP).xxviii The purpose of the RHCP is to subsidize the difference in rates between rural and urban areas for telecommunication services and as of 2012, to also provide a flat 65 percent discount on certain communications services "to promote the use of broadband services and facilitate the formation of healthcare provider consortia." The increased funding for broadband expansion to rural areas could dramatically improve telemedicine delivery in areas where access to care is most limited.

Food and Drug Administration (FDA) – New Digital Health Policies

The FDA released four new digital health policies aimed at encouraging digital health innovationxxix: (i) The Digital Health Innovation Action Planxxx; (ii) The Clinical and Patient Decision Support Softwarexxxi; (iii) The Changes to Existing Medical Software Policies Resulting from Section 3060 of the 21st Century Cures Act;xxxii and (iv) The Software as a Medical Device: Clinical Evaluation.xxxiii

Opioid Epidemic

Individuals suffering from substance abuse often encounter extreme difficulties maintaining sobriety after their discharge from inpatient detoxification facilities. Telemedicine has been successful in engaging this population in continuous monitoring and preventing relapse. When President Trump declared the opioid epidemic a national public health emergency, the declaration provided "for expanded access to telemedicine services, including services involving remote prescribing of medicine commonly used for substance abuse or mental health treatment." Updates to various state and federal laws, including the Ryan Haight Actxxxiv, will be needed to reflect the President's new opioid order.

VI. Conclusion and Predictions for 2018

The telemedicine landscape experienced significant changes over the past year, primarily at the state level. We expect additional changes in the near future as the healthcare marketplace incorporates telehealth into population health strategies, making it critical for businesses in this space to stay abreast of evolving regulations. As we look ahead to 2018, here are a few things that we expect to see evolving on the telehealth front: (i) continued IMLC involvement by states; (ii) continued expansion of telemedicine reimbursement in state Medicaid and commercial plans; (iii) phasing out of telemedicine pilot programs by health systems and transitioning into comprehensive telemedicine strategies system-wide; (iv) increased adoption of remote monitoring services; and (v) integration of mhealth apps into patient care and gamification of health and wellness through mobile apps.

Footnotes

i See "FSMB Survey Identifies Telemedicine as Most Important Regulatory Topic for State Medical Boards in 2016", dated December 15, 2016, available here: https://www.fsmb.org/Media/Default/PDF/Publications/20161215_annual_state_board_survey_sesults.pdf.

ii See, SB1107 (http://www.legis.state.tx.us/BillLookup/History.aspx?LegSess=85R&Bill=SB1107) (May 2017); see also 22 TAC 174.1 et seq. (Nov. 2017)

iii See, SB 726 (http://www.oklegislature.gov/BillInfo.aspx?Bill=sb726), effective November 1, 2017.

iv See, HB 1337 (https://iga.in.gov/legislative/2017/bills/house/1337#digest-heading), effective July 1, 2017.

v See, SB 213 (https://www.legislature.mi.gov/documents/2017-2018/publicact/pdf/2017-PA-0022.pdf), effective March 31, 2017.

vi This year Oklahoma adopted telemedicine practice standards that now explicitly permit the establishment of a physician-patient relationship via telemedicine without an in-person examination. See, SB 726, available at: https://legiscan.com/OK/text/SB726/id/1608914, (May 10, 2017.)

vii Arkansas passed and signed into law SB 146 on February 20, 2017, amending the state's telemedicine laws to redefine "originating site" to permit services to be provided wherever the patient is located at the time of the consult. See the changes to The Telehealth Act, available here: http://staging.arkleg.state.ar.us/ftproot/bills/2017R/public/SB146.pdf; see also, Act 203 (http://www.arkleg.state.ar.us/assembly/2017/2017R/Acts/ACT203.pdf)

viii Hawaii passed SB 2395 in 2016, effective as of January 1, 2017 to, among other things, remove originating site restrictions to permit patients to seek telemedicine care in their homes and at other non-medical sites. See changes to the Telemedicine Act, available here: http://www.capitol.hawaii.gov/session2016/bills/SB2395_CD1_.HTM.

ix See, SB 1107 (http://www.legis.state.tx.us/tlodocs/85R/billtext/pdf/SB01107F.pdf#navpanes=0)

x Vermont added the following new "originating site" definition: "Originating site" means the location of the patient, whether or not accompanied by a health care provider, at the time services are provided by a health care provider through telemedicine, including a health care provider's office, a hospital, or a health care facility, or the patient's home or another nonmedical environment such as a school-based health center, a university based health center, or the patient's workplace. See new SB 64 language, available here: http://legislature.vermont.gov/assets/Documents/2018/Docs/ACTS/ACT064/ACT064%20As%20Enacted.pdf.

xi See, LAC 46:XLV.408.

xii See, SB 291 available at: http://www.njleg.state.nj.us/bills/BillView.asp?BillNumber=S291, effective July 1, 2017.

xiii See, Illinois Public Act 100-0317, available at: http://www.ilga.gov/legislation/publicacts/fulltext.asp?Name=100-0317, effective July 1, 2018.

xiv See, Wisc. Med. Board, Rule 15-087, available at: https://docs.legis.wisconsin.gov/code/register/2017/737B/register/final/cr_15_087_rule_text/cr_15_087_rule_text.

xv See, NC Div. of Medical Assistance, Medicaid and Health Choice Manual, Clinical Coverage Policy No.: 1H.

xvi See, SC Health and Human Svcs. Dept., Physicians Provider Manual, p. 2-54 (Aug. 2017).

xvii See, NH Stat. 167:4-d, I (Sec. 43:1).

xviii See, SB 74 available at: http://www.akleg.gov/basis/get_bill.asp?session=29&bill=sb++74, effective July 31, 2017.

xix See, Pub. Act No. 17-115, available at: https://www.cga.ct.gov/2017/act/pa/pdf/2017PA-00115-R00HB-06012-PA.pdf. Conversely, Virginia explicitly authorized the practice of optometry and ophthalmology via telemedicine subject to certain conditions. See, Va. Code § 54.1-2400.01:2(B).

xx See, 22 TAC 174.4 and 174.5.

xxi Tennessee's passage included a delayed implementation until 2019.

xxii States actively participating in the IMLC now include Alabama, Arizona, Colorado, Idaho, Illinois, Iowa, Kansas, Maine, Minnesota, Mississippi, Montana, Nebraska, Nevada, New Hampshire, Pennsylvania, South Dakota, Tennessee, Utah, Washington, West Virginia, Wisconsin and Wyoming.

xxiii Telemedicine parity laws require insurers to cover services delivered via telemedicine to the same extent as coverage for the same service when delivered in-person. Parity laws may relate to coverage of the service or reimbursement of the service, or both, and may apply to the states' Medicaid programs, Medicaid managed care organizations, state employee health programs, or commercial payors operating in the state.

xxiv Massachusetts and Rhode Island are the only two states without definitive reimbursement rules for telemedicine in their FFS Medicaid programs; however, Massachusetts Medicaid managed care plans may reimburse for telemedicine.

xxv See, 2017 Mercer National Survey of Employer-Sponsored Health Plans.

xxvi In addition, two other bills impacting the Indian Health Services and the Veterans Administration were introduced this year. H.R. 1369 To Amend the Indian Health Care Improvement Act, was introduced to the U.S. House of Representatives to revise and extend the IHCIA. The bill established, among other things, the Indian Health Care Improvement Fund, which allows the Secretary to disburse funds for various of reasons including, among others, the use of telemedicine when appropriate. The Veterans Community Care and Access Act of 2017, introduced in the Senate, seeks to modernize the VA by allowing licensed VA physicians to practice telemedicine across state lines regardless of where they are located. The bill would supersede state licensing restrictions and prohibit states from taking legal action against VA providers for practicing telemedicine across state lines. Each of these bills aims to expand telemental health services to reduce suicide rates among the respective populations.

xxvii See, https://www.congress.gov/bill/115th-congress/senate-bill/870.

xxviii The cap has not been increased since 1996 despite the inclusion of skilled nursing facilities as a new class of provider.

xxix See, "Statement from FDA Commissioner Scott Gottlieb, M.D., on advancing new digital health policies to encourage innovation, bring efficiency and modernization to regulation" (Dec. 7, 2017), available at: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm587890.htm.

xxx Outlines the FDA's approach to ensuring timely access to high-quality, safe, and effective digital health products. The Plan contained several key goals, including increasing the number and expertise of digital health staff at the FDA, launching a digital health software precertification pilot program, and issuing guidance to modernize FDA policies.

xxxi Outlines the FDA's approach to clinical decision support software (CDS). CDS has many uses, including helping providers, and ultimately patients, identify the most appropriate treatment plan for their disease or condition. This draft guidance is intended to make clear what types of CDS would no longer be defined as a medical device, and thus not regulated by the FDA.

xxxii Outlines the FDA's interpretation of the types of software that are no longer considered medical devices. Under this draft guidance certain digital health technologies, such as mobile apps that are intended only for maintaining or encouraging a healthy lifestyle, generally fall outside the scope of the FDA's regulation.

xxxiii Establishes common principles for regulators to use in evaluating the safety, effectiveness, and performance of Software as a Medical Device.

xxxiv The Ryan Haight Online Pharmacy Consumer Protection Act restricts providers from prescribing controlled substances to patients who have not received an in-person medical evaluation. It currently contains seven separate "practice of telemedicine" exceptions that do not account for current clinical telemedicine practices. To address these deficiencies, the DEA, which enforces the Ryan Haight Act, has announced plans for a special telemedicine registration provision which would allow providers to use telemedicine to prescribe controlled substances without an in-person exam. Despite an expected 2017 release date, however, the DEA has yet to promulgate a new rule.

Originally published Law360 on December 20, 2017.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Events from this Firm
9 Jan 2018, Seminar, California, United States

The annual PIHRA Legal Update Seminars provides you with the latest California employment law related updates, compliance and regulatory issues, and the opportunity to network with legal practitioners and HR professionals.

17 Jan 2018, Seminar, Los Angeles, United States

The annual PIHRA Legal Update Seminars provides you with the latest California employment law related updates, compliance and regulatory issues, and the opportunity to network with legal practitioners and HR professionals.

18 Jan 2018, Seminar, Seoul, South Korea

Please join Sheppard Mullin and Lee & Ko for a cutting-edge discussion on “Trends in Intellectual Property – Keep Up or Get Left Behind” in view of key IP law developments in the United States.

 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement

    Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of www.mondaq.com

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

    Disclaimer

    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

    Registration

    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

    Cookies

    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

    Links

    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

    Mail-A-Friend

    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

    Emails

    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .

    Security

    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at enquiries@mondaq.com.

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions